These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16610949

  • 1. Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue.
    Smith AK, White PD, Aslakson E, Vollmer-Conna U, Rajeevan MS.
    Pharmacogenomics; 2006 Apr; 7(3):387-94. PubMed ID: 16610949
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome.
    Rajeevan MS, Smith AK, Dimulescu I, Unger ER, Vernon SD, Heim C, Reeves WC.
    Genes Brain Behav; 2007 Mar; 6(2):167-76. PubMed ID: 16740143
    [Abstract] [Full Text] [Related]

  • 3. Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome.
    Goertzel BN, Pennachin C, de Souza Coelho L, Gurbaxani B, Maloney EM, Jones JF.
    Pharmacogenomics; 2006 Apr; 7(3):475-83. PubMed ID: 16610957
    [Abstract] [Full Text] [Related]

  • 4. The validity of an empirical delineation of heterogeneity in chronic unexplained fatigue.
    Aslakson E, Vollmer-Conna U, White PD.
    Pharmacogenomics; 2006 Apr; 7(3):365-73. PubMed ID: 16610947
    [Abstract] [Full Text] [Related]

  • 5. Gene expression profile of empirically delineated classes of unexplained chronic fatigue.
    Carmel L, Efroni S, White PD, Aslakson E, Vollmer-Conna U, Rajeevan MS.
    Pharmacogenomics; 2006 Apr; 7(3):375-86. PubMed ID: 16610948
    [Abstract] [Full Text] [Related]

  • 6. An empirical delineation of the heterogeneity of chronic unexplained fatigue in women.
    Vollmer-Conna U, Aslakson E, White PD.
    Pharmacogenomics; 2006 Apr; 7(3):355-64. PubMed ID: 16610946
    [Abstract] [Full Text] [Related]

  • 7. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.
    Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F.
    Stress; 2007 Mar; 10(1):13-25. PubMed ID: 17454963
    [Abstract] [Full Text] [Related]

  • 8. Genetic evaluation of the serotonergic system in chronic fatigue syndrome.
    Smith AK, Dimulescu I, Falkenberg VR, Narasimhan S, Heim C, Vernon SD, Rajeevan MS.
    Psychoneuroendocrinology; 2008 Feb; 33(2):188-97. PubMed ID: 18079067
    [Abstract] [Full Text] [Related]

  • 9. The challenge of integrating disparate high-content data: epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome.
    Vernon SD, Reeves WC.
    Pharmacogenomics; 2006 Apr; 7(3):345-54. PubMed ID: 16610945
    [Abstract] [Full Text] [Related]

  • 10. [The HPA axis in the pathogenesis of chronic fatigue syndrome].
    Ursini F, Succurro E, Grembiale A, Gagliardi DA, Arturi F.
    Clin Ter; 2010 Apr; 161(5):461-4. PubMed ID: 20949245
    [Abstract] [Full Text] [Related]

  • 11. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
    Glass JM, Lyden AK, Petzke F, Stein P, Whalen G, Ambrose K, Chrousos G, Clauw DJ.
    J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
    [Abstract] [Full Text] [Related]

  • 12. Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome: are they associated with age at onset and specific symptoms?
    Ortega-Hernandez OD, Cuccia M, Bozzini S, Bassi N, Moscavitch S, Diaz-Gallo LM, Blank M, Agmon-Levin N, Shoenfeld Y.
    Ann N Y Acad Sci; 2009 Sep; 1173():589-99. PubMed ID: 19758204
    [Abstract] [Full Text] [Related]

  • 13. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia).
    Young AH, Sharpe M, Clements A, Dowling B, Hawton KE, Cowen PJ.
    Biol Psychiatry; 1998 Feb 01; 43(3):236-7. PubMed ID: 9494707
    [Abstract] [Full Text] [Related]

  • 14. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome.
    Van Den Eede F, Moorkens G, Van Houdenhove B, Cosyns P, Claes SJ.
    Neuropsychobiology; 2007 Feb 01; 55(2):112-20. PubMed ID: 17596739
    [Abstract] [Full Text] [Related]

  • 15. Chronic Fatigue Syndrome and DNA Hypomethylation of the Glucocorticoid Receptor Gene Promoter 1F Region: Associations With HPA Axis Hypofunction and Childhood Trauma.
    Vangeel E, Van Den Eede F, Hompes T, Izzi B, Del Favero J, Moorkens G, Lambrechts D, Freson K, Claes S.
    Psychosom Med; 2015 Oct 01; 77(8):853-62. PubMed ID: 26230484
    [Abstract] [Full Text] [Related]

  • 16. The HPA axis and the genesis of chronic fatigue syndrome.
    Cleare AJ.
    Trends Endocrinol Metab; 2004 Mar 01; 15(2):55-9. PubMed ID: 15036250
    [Abstract] [Full Text] [Related]

  • 17. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A, Hudson M, Jerjes W, Cleare AJ.
    Psychosom Med; 2005 Mar 01; 67(3):433-40. PubMed ID: 15911907
    [Abstract] [Full Text] [Related]

  • 18. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
    Inder WJ, Prickett TC, Mulder RT.
    Clin Endocrinol (Oxf); 2005 Mar 01; 62(3):343-8. PubMed ID: 15730417
    [Abstract] [Full Text] [Related]

  • 19. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats.
    Surapaneni DK, Adapa SR, Preeti K, Teja GR, Veeraragavan M, Krishnamurthy S.
    J Ethnopharmacol; 2012 Aug 30; 143(1):91-9. PubMed ID: 22771318
    [Abstract] [Full Text] [Related]

  • 20. Neuroaetiology of chronic fatigue syndrome: an overview.
    Sanders P, Korf J.
    World J Biol Psychiatry; 2008 Aug 30; 9(3):165-71. PubMed ID: 17853290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.